Patient-physician discussions about costs: Definitions and impact on cost conversation incidence estimates

BMC Health Services Research

Volumn 16, Issue 1, 2016, Pages

  Hunter, Wynn G ^a   Hesson, Ashley ^b   Kelly Davis, J ^c   Kirby, Christine ^c   Williamson, Lillie D ^d   Barnett, Jamison A ^e   Ubel, Peter A ^a,c,f  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c DUKE UNIVERSITY   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e Verilogue Inc   (United States)

^f DUKE UNIVERSITY   (United States)

Author keywords

Cost of illness; Health expenditures; Medical decision making; Out of pocket costs; Patient centered care; Patient physician communication

Indexed keywords

ADULT; AGED; COST; DOCTOR PATIENT RELATION; ECONOMICS; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HUMAN; INTERNAL MEDICINE; INTERPERSONAL COMMUNICATION; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; YOUNG ADULT;

ADULT; AGED; ARTHRITIS, RHEUMATOID; COMMUNICATION; COSTS AND COST ANALYSIS; FEMALE; FINANCING, PERSONAL; HEALTH EXPENDITURES; HUMANS; INTERNAL MEDICINE; MALE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85008354941     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/s12913-016-1353-2     Document Type: Article

References (47)

1. Cohen RA, Kirzinger WK. Financial burden of medical care: A family perspective. NCHS Data Brief. 2014;142:1-8.
2. Richman IB, Brodie M. A National study of burdensome health care costs among non-elderly Americans. BMC Health Serv Res. 2014;14(1):435. doi:10.1186/1472-6963-14-435.
3. Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18(4):381-90. doi:10.1634/theoncologist.2012-0279.
4. Cook K, Dranove D, Sfekas A. Does Major Illness Cause Financial Catastrophe? Health Serv Res. 2010;45(2):418-36. doi:10.1111/j.1475-6773. 2009.01049.x.
5. Himmelstein DU, Thorne D, Warren E, Woolhandler S. Medical bankruptcy in the United States, 2007: results of a national study. Am J of Med. 2009;122(8):741-6. doi:10.1016/j.amjmed.2009.04.012.
6. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97. doi:10.1056/NEJMra050100.
7. Zafar SY, Abernethy AP. Financial toxicity, Part I: A new name for a growing problem. Oncology (Williston Park, NY). 2013;27(2):80-1-149.
8. Moriates C, Shah NT, Arora VM. First, Do No (Financial) Harm. JAMA. 2013;310(6):577-8. doi:10.1001/jama.2013.7516.
9. Riggs KR, Ubel PA. Overcoming Barriers to Discussing Out-of-Pocket Costs With Patients. JAMA Intern Med. 2014;174(6):849-50. doi:10.1001/jamainternmed.2014.853.
10. Ubel PA, Abernethy AP, Zafar SY. Full disclosure-out-of-pocket costs as side effects. N Engl J Med. 2013;369(16):1484-6. doi:10.1056/nejmp1306826.
11. Zafar SY, Tulsky JA, Abernethy AP. It's time to have 'the talk': cost communication and patient-centered care. Oncology (Williston Park, NY). 2014;28(6):479-80.
12. Hunter WG, Ubel PA. The Black Box of Out-of-Pocket Cost Communication. A Path Toward Illumination. Ann Am Thorac Soc. 2014;11(10):1608-9. doi:10.1513/AnnalsATS.201410-475ED.
13. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA. 2003;290(7):953-8. doi:10.1001/jama.290.7.953.
14. Irwin B, Kimmick G, Altomare I, et al. Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist. 2014;19(11): 1135-40. doi:10.1634/theoncologist.2014-0117.
15. Schmittdiel JA, Steers N, Duru OK, et al. Patient-provider communication regarding drug costs in Medicare Part D beneficiaries with diabetes: A TRIAD Study. BMC Health Serv Res. 2010;10(1):164. doi:10.1186/1472-6963-10-164.
16. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004; 164(16):1749-55. doi:10.1001/archinte.164.16.1749.
17. Pollitz K, Cox C, Lucia K, Keith K. Medical Debt among People with Health Insurance. January 2014. http://kff.org/private-insurance/report/medicaldebt-Among-people-with-health-insurance/.
18. Hunter WG, Zhang CZ, Hesson A, et al. What Strategies Do Physicians and Patients Discuss to Reduce Out-of-Pocket Costs? Analysis of Cost-Saving Strategies in 1755 Outpatient Clinic Visits. Med Decis Making. 2016:1-11. doi:10.1177/0272989X15626384.
19. Bullock AJ, Hofstatter EW, Yushak ML, Buss MK. Understanding patients' attitudes toward communication about the cost of cancer care. J Oncol Pract. 2012;8(4):e50-8. doi:10.1200/JOP.2011.000418.
20. Danis M, Sommers R, Logan J, et al. Exploring Public Attitudes Towards Approaches to Discussing Costs in the Clinical Encounter. J Gen Intern Med. 2014;29(1):223-9. doi:10.1007/s11606-013-2543-9.
21. Sommers R, Goold SD, McGlynn EA, Pearson SD, Danis M. Focus Groups Highlight That Many Patients Object To Clinicians' Focusing On Costs. Health Affairs. 2013;32(2):338-46. doi:10.1377/hlthaff.2012.0686.
22. Jung OS, Guzzo T, Lee D, et al. Out-of-Pocket Expenses and Treatment Choice for Men With Prostate Cancer. Urology. 2012;80(6):1252-7. doi:10.1016/j.urology.2012.08.027.
23. McFarlane J, Riggins J, Smith TJ. SPIKE: A six-step protocol for delivering bad news about the cost of medical care. J Clin Oncol. 2008;26(25):4200-4. doi:10.1200/JCO.2007.15.6208.
24. Frankel RM, Stein T. A Better IDEA for Communicating with Patients about Costs. Virtual Mentor. 2006;8(3):150-3. doi:10.1001/virtualmentor.2006.8.3. jdsc1-0603.
25. Zafar SY. Financial Toxicity of Cancer Care: It's Time to Intervene. J Nat Cancer Inst. 2015;108(5):djv370-4. doi:10.1093/jnci/djv370.
26. Neumann PJ, Palmer JA, Nadler E, Fang C, Ubel P. Cancer Therapy Costs Influence Treatment: A National Survey Of Oncologists. Health Affairs. 2010; 29(1):196-202. doi:10.1377/hlthaff.2009.0077.
27. Schrag D, Hanger M. Medical Oncologists' Views on Communicating With Patients About Chemotherapy Costs: A Pilot Survey. J Clin Oncol. 2007;25(2):233-7. doi:10.1200/JCO.2006.09.2437.
28. Tseng C-W, Waitzfelder BE, Tierney EF, et al. Patients' willingness to discuss trade-offs to lower their out-of-pocket drug costs. Arch Intern Med. 2010;170(16):1502-4. doi:10.1001/archinternmed.2010.287.
29. Bestvina CM, Zullig LL, Rushing C, et al. Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014;10(3):162-7. doi:10.1200/JOP.2014.001406.
30. Shrank WH, Fox SA, Kirk A, et al. The effect of pharmacy benefit design on patient-physician communication about costs. J Gen Intern Med. 2006;21(4): 334-9. doi:10.1111/j.1525-1497.2006.00402.x.
31. Beran MS, Laouri M, Suttorp M, Brook R. Medication costs: The role physicians play with their senior patients. J Am Geriatr Soc. 2007;55(1):102-7. doi:10.1111/j. 1532-5415.2006.01011.x.
32. Tarn DM, Paterniti DA, Heritage J, Hays RD, Kravitz RL, Wenger NS. Physician communication about the cost and acquisition of newly prescribed medications. Am J Manag Care. 2006;12(11):657-64.
33. Beard AJ, Sleath B, Blalock SJ, et al. Predictors of rheumatoid arthritis patient-physician communication about medication costs during visits to rheumatologists. Arthritis Care Res. 2010;62(5):632-9. doi:10.1002/acr.20083.
34. Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277-88. doi:10.1177/1049732305276687.
35. Bradley EH, Curry LA, Devers KJ. Qualitative data analysis for health services research: Developing taxonomy, themes, and theory. Health Serv Res. 2007;42(4):1758-72. doi:10.1111/j.1475-6773.2006.00684.x.
36. Clopper CJ, Pearson ES. The Use of Confidence or Fiducial Limits Illustrated in the Case of the Binomial. Biometrika. 1934;26(4):404-13.
37. Machlin SR, Carper K. Out-of-Pocket Health Care Expenses by Age and Insurance Coverage, 2011. Statistical Brief #441. June 2014. http://meps. ahrq.gov/mepsweb/data-files/publications/st441/stat441.shtml. Accessed 1 Feb 2016.
38. Tarn DM, Paterniti DA, Good JS, et al. Physician-patient communication about dietary supplements. Patient Educ Couns. 2013;91(3):287-94. doi:10.1016/j.pec.2013.01.021.
39. Wilson IB, Schoen C, Neuman P, et al. Physician-Patient Communication About Prescription Medication Nonadherence: A 50-state Study of America's Seniors. J Gen Intern Med. 2007;22(1):6-12. doi:10.1007/s11606-006-0093-0.
40. Gellad WF, Huskamp HA, Li A, Zhang Y, Safran DG, Donohue JM. Use of Prescription Drug Samples and Patient Assistance Programs, and the Role of Doctor-Patient Communication. J Gen Intern Med. 2011;26(12):1458-64. doi:10.1007/s11606-011-1801-y.
41. Dennehy EB, Robinson RL, Stephenson JJ, et al. Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study. Curr Med Res Opin. 2015;31(6): 1165-77. doi:10.1185/03007995.2015.1029893.
42. Choi S, Hasche L, Nguyen D. Effects of depression on the subsequent year's healthcare expenditures among older adults: Two-year panel study. Psychiatr Q. 2015;86(2):225-41. doi:10.1007/s11126-014-9324-4.
43. Wolfe F, Michaud K. Out-of-pocket expenses and their burden in patients with rheumatoid arthritis. Arthritis Rheum. 2009;61(11):1563-70. doi:10.1002/art.24724.
44. Shrank WH, Joseph GJ, Choudhry NK, et al. Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most? Am J Manag Care. 2006;12(9):545-51.
45. Patel MR, Coffman JM, Tseng C-W, Clark NM, Cabana MD. Physician communication regarding cost when prescribing asthma medication to children. Clin Pediatr (Phila). 2009;48(5):493-8. doi:10.1177/0009922808330110.
46. Patel MR, Wheeler JRC. Physician-patient communication on cost and affordability in asthma care. Who wants to talk about it and who is actually doing it. Ann Am Thorac Soc. 2014;11(10):1538-44. doi:10.1513/AnnalsATS.201408-363OC.
47. Tseng C-W, Dudley RA, Brook RH, et al. Elderly patients' preferences and experiences with providers in managing their drug costs. J Am Geriatr Soc. 2007;55(12):1974-1980. doi:10.1111/j.1532-5415.2007.01445.x.